[Diagnosis and therapy for Behcet disease].
Shunsei
S
Hirohata
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D001528:Behcet Syndrome / Q000145:classification / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D003078:Colchicine / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage; D015235:HLA-B Antigens / Q000235:genetics; D059949:HLA-B51 Antigen; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D000069285:Infliximab; D012015:Reference Standards; D012017:Referral and Consultation; D012720:Severity of Illness Index
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D005938:Glucocorticoids; D015235:HLA-B Antigens; D059949:HLA-B51 Antigen; D007166:Immunosuppressive Agents; D000069285:Infliximab; D003078:Colchicine